MK Proteins Intrinsic Value
MK Proteins (MKPL) median intrinsic value is ₹10.14 from 9 valuation models (range ₹2–₹13), vs current price ₹5.07 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit MKPL share price screener.
MKPL Valuation Methods Summary — DCF, Graham Number & P/E
MK Proteins intrinsic value across 9 models vs current price ₹5.07 — upside/downside and value range per method. Browse MKPL cash flow statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2.40 | ₹1.92 - ₹2.88 | -52.7% | EPS: ₹0.20, Sector P/E: 12x |
| Book Value Method | asset | ₹12.68 | ₹11.41 - ₹13.95 | +150.1% | Book Value/Share: ₹18.42, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹10.14 | ₹9.13 - ₹11.15 | +100.0% | Revenue/Share: ₹98.42, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹10.14 | ₹9.13 - ₹11.15 | +100.0% | EBITDA: ₹14.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹12.68 | ₹10.14 - ₹15.22 | +150.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1.52 | ₹1.37 - ₹1.67 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1.68 | ₹1.51 - ₹1.85 | -66.9% | Revenue Growth: 9.9%, Adj P/E: 8.4x |
| ROE Based Valuation | profitability | ₹10.14 | ₹9.13 - ₹11.15 | +100.0% | ROE: 12.9%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹9.10 | ₹8.19 - ₹10.01 | +79.5% | EPS: ₹0.20, BVPS: ₹18.42 |
MKPL Intrinsic Value vs Market Price — All Valuation Models
MK Proteins fair value range ₹2–₹13 vs current market price ₹5.07 across 9 valuation models. Also explore MK Proteins stock price data download to track price trends across different timeframes.
MKPL Intrinsic Value Analysis — Undervalued or Overvalued?
MK Proteins median intrinsic value ₹10.14, current price ₹5.07 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of MKPL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of MK Proteins (MKPL) is ₹10.14 (median value). With the current market price of ₹5.07, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹1.52 to ₹12.68, indicating ₹1.52 - ₹12.68.
Is MKPL undervalued or overvalued?
Based on our multi-method analysis, MK Proteins (MKPL) appears to be trading below calculated value by approximately 100.0%.
MKPL Financial Health — Key Ratios vs Industry Benchmarks
MK Proteins financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 59.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 12.9% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.85x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
MKPL Cash Flow Quality — Operating & Free Cash Flow
MK Proteins operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-16 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹32 Cr | ₹29 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-10 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |